Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity
暂无分享,去创建一个
[1] A. Wróbel,et al. Stimulation of atypical cannabinoid receptor GPR55 abolishes the symptoms of detrusor overactivity in spontaneously hypertensive rats. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] A. Wein,et al. Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI‐RS 2019 , 2020, Neurourology and urodynamics.
[3] V. Uddandrao,et al. Antiobesity efficacy of asiatic acid: down-regulation of adipogenic and inflammatory processes in high fat diet induced obese rats , 2020, Archives of physiology and biochemistry.
[4] M. T. Islam,et al. Anti-Cancer Effects of Asiatic Acid, A Triterpene From Centilla Asiatica L: A Literature Review. , 2019, Anti-cancer agents in medicinal chemistry.
[5] L. Cui,et al. Asiatic Acid Attenuates Bone Loss by Regulating Osteoclastic Differentiation , 2019, Calcified Tissue International.
[6] F. Cruz,et al. Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019. , 2019, European urology focus.
[7] G. Keri̇moğlu,et al. Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice , 2019, International Urology and Nephrology.
[8] S. Bae,et al. Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress , 2019, BMC Complementary and Alternative Medicine.
[9] J. Dudka,et al. Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity , 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.
[10] M. Tantisira,et al. Safety and Pharmacokinetics of Standardized Extract of Centella asiatica (ECa 233) Capsules in Healthy Thai Volunteers: A Phase 1 Clinical Study , 2019, Planta Medica.
[11] T. Manivasagam,et al. Asiatic Acid Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress and Apoptosis Via AKT/GSK-3β Signaling Pathway in Wistar Rats , 2019, Neurotoxicity Research.
[12] A. Bishayee,et al. Pentacyclic triterpenes: New tools to fight metabolic syndrome. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[13] J. Dudka,et al. Inhibition of Rho kinase by GSK 269962 reverses both corticosterone‐induced detrusor overactivity and depression‐like behaviour in rats , 2018, European journal of pharmacology.
[14] Chandragouda R. Patil,et al. Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise , 2018, Front. Pharmacol..
[15] Huaxi Xu,et al. Asiatic Acid Prevents Oxidative Stress and Apoptosis by Inhibiting the Translocation of α-Synuclein Into Mitochondria , 2018, Front. Neurosci..
[16] J. Lou,et al. Centella asiatica triterpenes for diabetic neuropathy: a randomized, double-blind, placebo-controlled, pilot clinical study. , 2018, Esperienze dermatologiche.
[17] M. Yin,et al. Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress , 2018, Epilepsy Research.
[18] Xianting Ding,et al. Pharmacological Review on Asiatic Acid and Its Derivatives: A Potential Compound , 2018, SLAS technology.
[19] A. Weintraub,et al. Overactive Bladder Syndrome: Evaluation and Management , 2018, Current Urology.
[20] C. Kaya,et al. A comparison of normal and high post-void residual urine and urodynamic parameters in women with overactive bladder , 2017, Turkish journal of obstetrics and gynecology.
[21] Xiaoning He,et al. Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast , 2017, International Urology and Nephrology.
[22] R. Franzen,et al. Puzzling Out Synaptic Vesicle 2 Family Members Functions , 2017, Front. Mol. Neurosci..
[23] F. Wei,et al. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[24] Xuming Deng,et al. Asiatic acid enhances Nrf2 signaling to protect HepG2 cells from oxidative damage through Akt and ERK activation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] Demin Zhou,et al. Selective oxidation-reduction and esterification of asiatic acid by Pestalotiopsis microspora and anti-HCV activity , 2017 .
[26] J. Dudka,et al. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] T. Rechberger,et al. The influence of Rho‐kinase inhibition on acetic acid‐induced detrusor overactivity , 2017, Neurourology and urodynamics.
[28] Wu Jiang,et al. Neuroprotective effect of asiatic acid against spinal cord injury in rats. , 2016, Life sciences.
[29] S. Radomski,et al. Review of the epidemiology of overactive bladder. , 2016, Research and reports in urology.
[30] T. Rechberger,et al. Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms , 2016, International Urogynecology Journal.
[31] C-H Chang,et al. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment , 2016, Spinal Cord.
[32] M. Mong,et al. Antibacterial effects and action modes of asiatic acid. , 2015, BioMedicine.
[33] T. Rechberger,et al. A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. , 2015, Journal of pharmacological and toxicological methods.
[34] Eric J. Gonzalez,et al. The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes , 2015, TheScientificWorldJournal.
[35] A. Kanai,et al. Effect of botulinum toxin A on urothelial‐release of ATP and expression of SNARE targets within the urothelium , 2015, Neurourology and urodynamics.
[36] Jane-Dar Lee,et al. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.
[37] H. Kuo,et al. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis. , 2013, Urology.
[38] E. Walters,et al. Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. , 2013, The Journal of clinical investigation.
[39] V. Khullar,et al. Biomarkers in overactive bladder , 2013, International Urogynecology Journal.
[40] Q. Lei,et al. VEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity , 2012, BMC Physiology.
[41] Sung-Ho Chen,et al. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome. , 2012, Urology.
[42] S. Oger,et al. Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity. , 2012, European urology.
[43] L. Cardozo,et al. Overactive bladder: diagnosis and management. , 2012, Maturitas.
[44] F. Cruz,et al. Neurotrophins in the Lower Urinary Tract: Becoming of Age , 2011, Current neuropharmacology.
[45] K. Andersson,et al. Rodent models for urodynamic investigation , 2011, Neurourology and urodynamics.
[46] A. Wein,et al. Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.
[47] F. Cruz,et al. Biomarkers in Overactive Bladder: A New Objective and Noninvasive Tool? , 2011, Advances in urology.
[48] K. Coyne,et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature , 2011, International journal of clinical practice.
[49] J. Kaleczyc,et al. The influence of botulinum toxin type A (BTX) on the immunohistochemical characteristics of noradrenergic and cholinergic nerve fibers supplying the porcine urinary bladder wall. , 2011, Polish journal of veterinary sciences.
[50] O. B. Hani,et al. Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms , 2011, International neurourology journal.
[51] M. Drake,et al. Animal models in overactive bladder research. , 2011, Handbook of experimental pharmacology.
[52] K. Andersson. Detrusor myocyte activity and afferent signaling , 2010, Neurourology and urodynamics.
[53] Luyong Zhang,et al. Synthesis and Biological Evaluation of Asiatic Acid Derivatives as Inhibitors of Glycogen Phosphorylases , 2009, Chemistry & biodiversity.
[54] C. Harding,et al. Is low bladder compliance predictive of detrusor overactivity? , 2009, Neurourology and urodynamics.
[55] R. Dipasquale. Effective Use of Herbal Medicine in Urinary Tract Infections , 2008, Journal of dietary supplements.
[56] Y. Yoshimura,et al. The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch‐induced acetylcholine release in female rat bladder , 2007, Neurourology and urodynamics.
[57] H. Koepsell,et al. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. , 2007, European urology.
[58] W. Schaefer. Re: Is the bladder a reliable witness for predicting detrusor overactivity? H. Hashim and P. Abrams. J Urol, 175: 191-195, 2006. , 2006, The Journal of urology.
[59] D. Rapp,et al. Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. , 2006, The Journal of urology.
[60] A. Wein,et al. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. , 2006, The Journal of urology.
[61] A. Brading. Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function , 2006, The Journal of physiology.
[62] R. Levin,et al. Effects of castration on female rabbit bladder physiology and morphology. , 2004, Urology.
[63] R. Saito,et al. Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. , 2004, The Journal of urology.
[64] L. Cardozo,et al. The role of estrogens in female lower urinary tract dysfunction. , 2003, Urology.
[65] M. Fall,et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. , 2002 .
[66] C. Dubeau,et al. Quest for a detrusor overactivity index. , 2002, The Journal of urology.
[67] G. Belcaro,et al. Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella asiatica: A Prospective, Placebo-Controlled Randomized Study , 2001, Angiology.
[68] MJ Drake,et al. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function , 2001, The Lancet.
[69] M. Damaser,et al. Effects of anesthesia on cystometry and leak point pressure of the female rat. , 2001, Life sciences.
[70] W. C. Groat. A neurologic basis for the overactive bladder , 1997 .
[71] K. Moore,et al. Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. , 1997, Laboratory investigation; a journal of technical methods and pathology.